Clinical Trials

84 enrolled

Pancreatic Neoplasms

NCT07533708 2026-04-16

A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours

48 enrolled

mCRPC or Advanced/Metastatic Solid Tumors

NCT07533942 2026-04-16

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

30 enrolled

CNS

Meningioma

NCT07534813 2026-04-16

A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors

16 enrolled

Advanced Solid Tumors

NCT07535112 2026-04-16

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

130 enrolled

Advanced/Metastatic Colorectal Adenocarcinoma

NCT01481532 2026-04-15

Open Label Clinical Trial of Intravenous Crotoxin Part 3

24 enrolled

Tumor-Agnostic

Neoplasms

NCT07518043 2026-04-15

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

DermatologicGenitourinary

174 enrolled

Carcinoma, Transitional Cell, Melanoma

NCT07529808 2026-04-15

ChefHat-001

164 enrolled

Adenocarcinoma, Colonic Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT07530133 2026-04-15

Clinical Trial on Safety and Efficacy of Thoracoabdominal Endoscopic Surgical System for Pediatric Surgery

GynecologicOther neoplasm

64 enrolled

Indications for Laparoscopic Thoracic and Abdominal Surgery in Children

NCT07530666 2026-04-15

Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

58 enrolled

Cachexia, Neoplasms

NCT07531095 2026-04-15

DeLLphi-313

160 enrolled

Small Cell Lung Carcinoma

NCT07532148 2026-04-15

Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

24 enrolled

Gynecologic

Ovarian Neoplasms

NCT06622057 2026-04-14

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

195 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT07450599 2026-04-14

CHINANEO

250 enrolled

High-Risk Localized Prostate Cancer

NCT07502300 2026-04-14

A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer

562 enrolled

Small Cell Lung Carcinoma

NCT07527221 2026-04-14

Safety and Tolerability of ZE74-0282 in Healthy Volunteers

MyeloidOther hematologic neoplasm

40 enrolled

Polycythemia, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07527832 2026-04-14

An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.

Not yet recruiting

1,000 enrolled

Hemorrhage, Colorectal Neoplasms

NCT07527858 2026-04-14

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

170 enrolled

Advanced Microsatellite Stable Colorectal Cancer

NCT07529405 2026-04-14

CurbMF

386 enrolled

Lymphoid

Mycosis Fungoides

NCT07529717 2026-04-14

CRIUS-1

42 enrolled

Prostatic Neoplasms

NCT07529951 2026-04-14

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

60 enrolled

Myeloid

Polycythemia Vera, Primary Myelofibrosis

NCT02802423 2026-04-13

Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

44 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07408258 2026-04-13

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

20 enrolled

Advanced Solid Tumor

NCT07509684 2026-04-13

A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors

190 enrolled

Advanced Solid Tumors

NCT07518186 2026-04-13

TRIlogy-5

700 enrolled

Plasma cell

Multiple Myeloma

NCT07520006 2026-04-13

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

LymphoidOther hematologic neoplasm

150 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07522151 2026-04-13

Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer

874 enrolled

Locally Advanced Gastric or Gastroesophageal Junction Cancer

NCT07522476 2026-04-13

A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma

30 enrolled

Cholangiocarcinoma

NCT07524140 2026-04-13

Study of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts.

60 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07524257 2026-04-13

ResQ1010-NSCLC: NAI + Chemoimmunotherapy vs Chemoimmunotherapy for First-Line Advanced/Metastatic NSCLC

494 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07524322 2026-04-13

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

63 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07525141 2026-04-13

A Study of JNJ-1761981 in Participants With Solid Tumors

66 enrolled

Tumor-Agnostic

Neoplasms

NCT07525206 2026-04-13

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

700 enrolled

Colorectal Neoplasms

NCT07526792 2026-04-13

SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

406 enrolled

Phase 2/3 Not yet recruiting

Carcinoma, Transitional Cell

NCT07413939 2026-04-09

BREnnA

650 enrolled

Breast

HER2-positive Breast Cancer

NCT07514975 2026-04-09

First-In-Human Study of KHN922 for Injection

276 enrolled

Advanced Solid Tumors Cancer

NCT07519564 2026-04-09

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

18 enrolled

Cachexia, Neoplasms

NCT07519655 2026-04-09

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

DermatologicGastrointestinalThoracic

250 enrolled

Esophageal Neoplasms, Lung Neoplasms, Melanoma

NCT07519772 2026-04-09

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

200 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07415031 2026-04-08

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

170 enrolled

Solid Tumors

NCT07516093 2026-04-08

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

LymphoidOther hematologic neoplasm

620 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07518147 2026-04-08

A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment

438 enrolled

Stomach Neoplasms

NCT07518173 2026-04-08

A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and Pertuzumab in Patients With First-line HER2-positive Recurrent or Metastatic Breast Cancer

596 enrolled

Breast

HER2-positive Breast Cancer

NCT07518329 2026-04-08

Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

LymphoidOther hematologic neoplasm

46 enrolled

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

NCT07170592 2026-04-07

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients

24 enrolled

Treatment-Refractory Solid Tumors

NCT07426757 2026-04-07

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

120 enrolled

Advanced Malignancies

NCT07488585 2026-04-07

THYMAL 01

30 enrolled

Head & Neck

Thyroid Diseases, Thyroid Nodule

NCT07492381 2026-04-07

A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer

50 enrolled

Prostatic Neoplasms

NCT07513376 2026-04-07

INTerpath-014

876 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07513454 2026-04-07

A Phase 2 Study of HW211026 in Participants With Actinic Keratosis